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Phosphatidylinositol (PI) is a precursor for an important class of phospholipids, the phosphatidylinositol polyphosphates. 
Because renal myo-inositol levels may vary under both physiological (e.g., antidiuretic) and pathophysiological (e.g., 
diabetic) conditions, the formation of PI from CDP-diacylglycerol (CDP-DG) and myo-inositol via phosphatidylinositol 
synthase and the regulation of this enzyme have important implications for the cellular biology of renal epithelia. We 
sought to understand the role of PI synthase by determining its subcellular localization, kinetic properties and regulation 
in rabbit proximal tubule cells. Proximal tubule cells were isolated from New Zealand White rabbits. The subcellular 
synthesis of PI was assessed by [ 32 PJorthophosphate labelling with subsequent subcellular fractionation. Labelling of PI 
was time-dependent and consistent with the rapid incorporation of 32P04 into basolateral, brush-border, microsomal and 
nuclear fractions. Pulse-chase labelling of proximal tubule cells was consistent with the formation of PI in microsomal 
fraction of the proximal tubule cells in addition to both brush-border and basolateral membranes. Conversely, 
phosphatidylcholine, phosphatidylethanolamine and phosphatidylglycerol displayed radiolabelling patterns consistent 
with microsomal synthesis alone. The in situ formation of phosphatidylinositol was substantiated by the direct 
measurement of phosphatidylinositol synthase activity in basolateral, brush-border and microsomal fractions. The 
apparent K, values for myo-inositol were 0.32 f 0.19, 0.39 f 0.21 and 0.23 f 0.05 mM, and for CDP-DG were 
0.12 f 0.02, 0.14 f 0.05 and 0.12 f 0.02 mM in basolateral, brush-border and microsomal fractions, respectively. I$,,, 
values for phosphatidylinositol formation were slightly, but not significantly greater, in microsomal than for plasma 
membrane fractions. Moreover, based on enzymatic enrichment data, plasma membrane PI synthase activity could not 
be explained by microsomal cross-contamination alone. PI synthase activity was inhibited by co-incubation with PI 
without differences among the cellular fractions. Intracellular myo-inositol concentration in the proximal tubule cells as 
measured by gas-liquid chromatography was 20.5 mM, significantly greater than the apparent K, values for 
myo-inositol. In conclusion, the in situ synthesis of phosphatidylinositol occurs in several membrane fractions; the 
kinetic properties of phosphatidylinositol synthase appear to be similar in each fraction; and phosphatidylinositol 
synthase in proximal tubule cells is inhibited by its own formation product. These data suggest that myo-inositol 
concentration alone is unlikely to be an important regulator of the chemical mass of phosphatidylinositol at the levels of 
this polyol observed in rabbit kidney. 
Introduction 
The now classic pathway whereby inositol trisphos- 
phate and diacylglycerol are produced from the 
hormone-stimulated hydrolysis of phosphatidylinositol 
bisphosphate (PIP,) is well documented in the renal 
epithelia [1,2] as well as many other non-renal tissues 
[3,4]. However, a clear understanding of the detailed 
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kinetics of inositol lipid formation and degradation 
remains elusive. For example, it has yet to be clearly 
established whether concomitant hydrolysis of phospha- 
tidylinositol4-monophosphate and phosphatidylinositol 
occur in addition to phosphatidylinositol 4,5-bisphos- 
phate following hormone-stimulated activation of phos- 
pholipase C. Observed changes in the radiolabeling of 
PI and PIP following phospholipase C activation have 
been explained in part on the rapid synthesis and con- 
version of these products to PIP,, possible in part 
because of the liberation of free myo-inositol from the 
dephosphorylation of inositol monophosphate. A neces- 
sary (although not sufficient) requirement for this model 
of hormone-stimulated inositol lipid hydrolysis, how- 
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ever, is the demonstration of in situ phospholipid for- 
mation at the site of action of candidate agonists. This 
has not been demonstrated previously in renal epithelia. 
Phosphatidylinositol is synthesized from CDP-diacyl- 
glycerol and myo-inositol by phosphatidylinositol syn- 
thase (CDP-DG : myo-inositol 3-phosphatidylinositol 
transferase, EC 2.7.8.11). The subcellular site of PI 
synthase, however, remains controversial. Phosphatidyl- 
inositol has been widely reported to be formed exclu- 
sively within the microsomal fraction of cells with sub- 
sequent insertion into the plasma membrane [5,6]. Re- 
cently, distinct PI synthase activities have been identi- 
fied in both the plasma membrane and the endoplasmic 
reticulum of GH3 pituitary cells [7] consistent with the 
in situ production of PI within plasma membranes. 
Canine cardiac sarcoplasmic reticulum and plasma 
membrane have also been suggested to possess phos- 
phatidylinositol synthase activity [8]. Other investiga- 
tors, however, have been unable to confirm the ex- 
istence of non-microsomal synthase activity in a variety 
of cell types [9]. We sought to evaluate this issue by 
investigating the formation of phosphatidylinositol in 
renal proximal tubule cells. These cells are amenable to 
similar studies, not only because of the ability to readily 
fractionate their subcellular components, but also be- 
cause they possess two biochemically and physio- 
logically distinct plasma membrane domains, the 
brush-border and basolateral membranes. Potential dif- 
ferences in hormonal responsiveness between these 
plasma membrane domains could therefore, in theory, 
be the product of differences in phosphatidylinositol 
metabolism. 
Materials and Methods 
New Zealand white rabbits of either sex were used. 
Collagenase type II was obtained from Worthington 
Biochemical (Freehold, NJ)). High-performance TLC 
60 plates were from E. Merck (Montreal, Canada). 
Phospholipids standards including CDP-diacylglycerol 
were from Sigma (St. Louis, MO) or Sedary (Port 
Huron, MI). Tri-n-octylamine was from Aldrich Chem- 
ical. Freon was from Matheson Gas Products. [32P]Or- 
thophosphate (carrier-free), myo-[2-3H]inositol and 
aqueous liquid scintillant were from Amersham (Arlin- 
gton Heights, IL). L-c&o-Inositol standard was the 
generous gift of Dr. B.W. Agranoff (University of 
Michigan, Ann Arbor, MI). Tri-sil concentrate and Re- 
acti-vials (0.3 ml) were from Pierce Chemical. 
Proximal tubule cell isolation 
Cells were isolated from renal cortical homogenates 
following the protocol of Vinay et al. [lo]. Briefly, 
rabbits were killed under pentobarbital anesthesia, the 
kidneys removed, decapsulated and cortical slices dis- 
sected free. Cortical sections were minced thoroughly 
and suspended in a buffer consisting (in mM) of NaCl 
115, KC1 3.9, KPO, 1.2, MgSO, 1.2, MgCl,, CaCl, 2.6, 
NaHCO, 30, glucose 5, butyrate 1, alanine 1, mannitol 
2.5 and lactate 5. Thereafter, cells were subjected to 
collagenase digestion for 30 min at 37 o C. The digestate 
was then centrifuged at 30 x g for 4 min. The resultant 
pellet was resuspended in a solution containing 45% 
Percoll and gradient centrifugation was performed at 
35 000 X g for 30 min. ‘Band 4’ representing proximal 
tubule cells was removed and resuspended in a 5 mM 
Tris-HCl buffer (pH 7.4). Cells were pelleted at low 
speed and resuspended in this buffer three times to 
remove the Percoll. The entire cell isolation procedure 
was conducted at 4” C. 
Membrane vesicle preparation 
Brush-border and basolateral membranes were pre- 
pared as described by Morrison and Pascoe [ 111. An 
aliquot of the proximal tubule cell suspension in buffer 
was homogenized in a tissuemizer for four 30 s bursts at 
full speed while on ice. The homogenate was filtered 
through a 40 pm nylon mesh and the filtrate was 
centrifuged at 3500 x g for 5 min at 4 o C. The super- 
natant was saved and MgCl, added to achieve a final 
concentration of 10 mM. The solution was then allowed 
to stand on ice for 15 min. The resultant pellet con- 
tained crude basolateral membranes and the super- 
natant brush-border membranes. 
The supernatant was centrifuged at 35000 X g for 30 
min and the resultant pellet was resuspended in a 
volume of 300 mM mannitol and 5 mM Tris-HCl buffer 
(pH 7.5). It was then centrifuged twice at 35 000 X g for 
30 min at 4” C. The resultant pellet was resuspended in 
30 vol of 150 mM NaCl, 50 mM Tris-HCl (pH 7.4) and 
10 mM /3-mercaptoethanol and subjected to a single 
Polytron burst. EDTA was added to yield a final con- 
centration of 15 mM and the solution was stirred on ice 
for 10 min. Percoll was then added to yield a final 
concentration of 15% and the solution was centrifuged 
at 25 000 X g for 30 min at 4” C. The second band from 
the top was recovered as enriched basolateral mem- 
brane. This fraction was removed, resuspended in the 
latter buffer without Percoll and centrifuged at 34000 
x g. The final pellet was used as enriched basolateral 
membranes. 
Subcellular fractions preparation 
The further subcellular fractionation of proximal 
tubule cells followed an adaptation of a protocol of 
Seyfred and Wells as originally described for hepato- 
cytes [12]. Aliquots of the proximal tubule cell sus- 
pended in homogenizing buffer (HB) were homogenized 
twice in a tissuemizer for 30 s at 4O C. This buffer 
consisted of 250 mM sucrose, 1 mM EDTA, 10 mM 
NaN,, 20 mM NaF, 75 mg/l phenylmethylsulfonyl 
fluoride and 10 mM Tricine (pH 8.0). The homogenate 
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was then centrifuged at 1500 X g for 5 min, the super- 
natant removed and the pellet was resuspended in the 
same homogenizing buffer. The suspension was respun 
at 1500 x g and the resultant supernatant was com- 
bined with that of the first centrifugation. The resultant 
pellet contained the nuclear fraction and was resus- 
pended in 25 ml of HB containing 20% Percoll and 
centrifuged at 10000 x g for 20 min. The pellet was 
further suspended in 10 ml of a buffer consisting of (in 
mM) sucrose 250, MgCl, 10, Tricine 10 (pH 8.0). This 
suspension was centrifuged at 1500 X g for 5 min, the 
supernatant discarded and the pellet was sequentially 
resuspended in 2 ml of the latter buffer and to this was 
added 8 ml of a buffer consisting of sucrose 2.3 M, 
MgCl, 10 mM, Tricine 10 mM (pH 8.0). This mixture 
was then centrifuged at 100000 X g for 60 min; the 
final pellet was recovered as the nuclear fraction. 
The combined supernatants frm the initial spins were 
sequentially centrifuged at 3600 X g for 5 min, the 
resultant supernatant and pellet contained the crude 
microsomes and mitochondria, respectively. 
The pellet containing the mitochondria was resus- 
pended in 5.5 ml of HB and to it 4.5 ml of Percoll was 
added and the mixture centrifuged at 10000 x g for 20 
min. The resultant pellet was diluted in 10 ml of HB 
and centrifuged at 3600 x g for 5 min. The final pellet 
was recovered as the enriched mitochondria. 
The supematant containing the microsomes was 
centrifuged at 18000 x g for 10 min, the pellet was 
discarded and the supernatant was spun at 100000 X g 
for 60 min. The final pellet was recovered as the en- 
riched microsomes. 
Assessment of fraction enrichment 
Marker enzymes were used to assess the purity of 
each fraction. These included fructose 1,6-bisphos- 
phatase [13], Na+/K+-ATPase [14], alkaline phos- 
phatase [15], cytochrome-c reductase [16], succinate de- 
hydrogenase [16], and DNA [17] for whole proximal 
tubule cell, basolateral membrane, brush-border mem- 
brane, microsomal, mitochondrial and nuclear fractions, 
respectively. Substrates for each enzyme marker were 
fructose 1,6-phosphate for fructose 1,6_bisphosphatase, 
ATP for Na+/K+-ATPase, p-nitrophenol for alkaline 
phosphatase, cytochrome c reduced for cytochrome-c 
reductase and succinate oxidized for succinate dehydro- 
genase. 
j2P0, labeling 
The pellet representing enriched proximal tubule cells 
was resuspended in a buffer consisting of (in mM) 
Tris-HCl (pH 7.4) 15.4, NaCl 140 and glucose 5.6. 
Carrier-free [32P]orthophosphate was added to the cell 
suspension to attain a final concentration of 100 pCi/ml 
for the standard labelling experiments and 500 pCi/ml 
for the pulse-chase experiments. The mixture was then 
placed in a shaking water bath and gassed with 95% 0, 
and 5% CO, at 37” C. For standard labelling experi- 
ments, the cells were incubated for varying periods of 
time as detailed below. For pulse-chase labelling, the 
cells were exposed to radiolabel for 30 min, pelleted at 
500 rpm for 3 min and then resuspended in a radio- 
label-free Krebs-Henseleit buffer where the incubation 
was allowed to proceed for 30 and 60 min. For both 
standard and pulse-chase labelling, subcellular 
fractionation was initiated by placing aliquots of sus- 
pended cells in 10 vol. of ice-cold HB. 
Phospholipid extraction, separation and identification 
Prior to lipid extraction, a small aliquot consisting of 
5% of each fraction was removed for protein determina- 
tion utilizing the fluorescamine reagent [18]. Bovine 
serum albumin was used as standard. Lipids were ex- 
tracted by the addition of chloroform/methanol/O.5 M 
HCl (10 : 20 : 1, v/v) to the isolated fractions. The mix- 
ture was vortexed and centrifuged at 270 x g for 10 min 
at 4” C to effect phase separation. The upper phase was 
removed, the protein pellet at the interface deflected 
and the lower phase recovered. Both upper and lower 
phases were back-extracted and the lower phases were 
pooled and evaporated to dryness under a stream of N,. 
The lipid extract was resuspended in 50 ~1 of chloro- 
form/methanol (1 : 1, v/v). 
Extracted phospholipids and phospholipid standards 
were separated on high-performance thin-layer chro- 
matography plates. Phosphatidylcholine, phosphatidic 
acid, phosphatidylethanolamine, phosphatidylserine and 
sphingomyelin were separated two-dimensionally. The 
first dimension utilized chloroform/ methanol/ ammo- 
nium hydroxide/water (65 : 35 : 5 : 0.6, v/v) and the 
second dimension utilized chloroform/ acetone/ 
methanol/acetic acid/water (45 : 19 : 10 : 15 : 2, v/v). In 
contrast to other reports [ll], it was observed that 
phosphatidylinositol could not be reliably resolved from 
phosphatidylserine using this system. Phosphatidyl- 
inositol separations were thus conducted one-dimen- 
sionally in a solvent system consisting of chloroform/ 
methanol/40% methylamine (65 : 35 : 10, v/v). Phos- 
pholipids were identified both by autoradiography and 
by comparison to authentic standards. For routine anal- 
ysis, plates were exposed to I, vapor, and phospholipids 
scraped and quantitated by liquid scintillation counting. 
Phosphatidylinositol synthase assay 
Synthase activity was assayed following the protocol 
of Imai and Gershengorn [7]. Isolated subcellular mem- 
branes were suspended in 50 ~1 of buffer containing 
Tris-HCl 100 mM (pH 7.5) EGTA 1 mM, MgCl, 3 
mM, MnCl, 3 mM, 0.1% Triton X-100, 0.1 to 10 mM 
CDP-dipalmitoylglycerol and 0.1 to 10 mM myo-in- 
ositol containing lo6 dpm/nmol of myo-[2-3H]inositol. 
The incubation proceeded for either 10 or 20 min at 
37” C and was terminated by the addition of 1 ml of 
chloroform/methanol/concentrated HCl (100 : 100 : 1, 
v/v). Phase separation was facilitated by the addition of 
0.25 ml of 10 mM EDTA. The lower phase was re- 
moved and the upper phase was back extracted with 
chloroform. The lower phases were then combined, 
evaporated to dryness under N, and the [ 3H]phosphati- 
dylinositol formed was separated by high-performance 
TLC as above. Phosphatidylinositol was identified by 
co-migration with authentic standards and quantitated 
by liquid scintillation counting. 
dried samples, 25 ~1 of dry pyridine was added, the vials 
were capped, vortexed and then heated at 70 o C for 15 
min. This was followed by the addition of 25 ~1 of a 
Tri-sil : pyridine mixture (3 : 10) to the still-warm sam- 
ples which again were vortex-mixed and heated for 20 
min at 70” C. The samples were dried under N, flow 
and resuspended in HPLC grade acetonitrile for GC 
injection. 
Myo-Inositol quantitation 
Isolated proximal tubule cells were resuspended in a 
phosphate-saline buffer (pH 7.4) and pelleted at low 
speed to remove Percoll. The tissue pellet was homoge- 
nized in 7% trichloroacetic acid and allowed to stand on 
ice for 5 min. r_-chiro-Inositol was added as an internal 
standard at 5 mol/mg tissue protein. The suspension 
was subsequently centrifuged at 30 x g for 5 min at 
4” C. The pellet was saved for protein determination 
and the supematant was mixed with a solution of 26% 
tri-n-octylamine and Freon to remove the trichloro- 
acetic acid. The suspension was well mixed and centri- 
fuged at 270 X g for 10 min at 4’C to affect phase 
separation. The upper phase was used for derivatization 
and mass measurement. 
Separation and detection of the trimethylsily deriva- 
tives of myo-inositol and L-chiro-inositol were per- 
formed on a Hewlett-Packard 5890 chromatograph with 
an SP-2380 capillary column (Supelco, Bellefonte, PA). 
Split injection (33 : 1) and flame ionization detection 
were employed. Nitrogen was used as the carrier gas at 
a flow-rate of 1.7 ml/min. Injector and detector tem- 
peratures were 200°C column temperature was 150°C 
and ramped at 3 C”/min. Under these conditions L- 
chiro- and myo-inositol eluted at 4.5 and 7.0 min, re- 
spectively. myo-Inositol mass was calculated from the 
ratio of myo-inositol and L-chiro-inositol peak areas. 
Results 
An adaptation of the method described by Rit- 
tenhouse [19] was employed. 50 ~1 aliquots of tissue 
extracts obtained as above were applied to clean and 
dry reacti-vials. An equal volume of GC-grade pyridine 
was also added, vials were capped, vortexed and dried 
under a stream of N,. Two other rinses of pyridine were 
performed to assure complete removal of water. To the 
The enrichments of the isolated subcellular fractions 
and whole tubule cell homogenates are displayed in 
Table I. Proximal tubule cells obtained from ‘band 4’ of 
the Percoll gradient centrifugation displayed a marked 
increase in fructose 1,6_bisphosphatase activity, com- 
parable to that originally reported by Vinay [lo]. 
Brush-border and basolateral membranes were enriched 
for alkaline phosphatase and Na+/K+-ATPase activity, 
respectively, and were comparably de-enriched for the 
microsomal, mitochondrial and nuclear markers. Cyto- 
chrome-c reductase was a significant contaminant of 
TABLE I 
Enzyme profiles and DNA deteminations of subcellular fractions 
F’TC denotes proximal tubular cells. Results are expressed as the mean+ SE. of micromol of substrate converted per min per mg of protein of at 
least three separate experiments. The numbers in parentheses refer to the specific activity of the enzyme relative to the proximal tubule cell 
homogenate for the subcelhrlar fractions and relative to the cortical homogenate for the proximal tubule cells. Substrates are as indicated in the 
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0.098 f 0.001 0.054 f 0.005 
0.063 f 0.001 0.0175 f 0.005 
(0.6) (0.3) 
0.033 + 0.006 0.012 f 0.001 
(0.3) (0.2) 
0.208 f 0.003 0.155 *0.006 
(2.1) (2.9) 
0.328 + 0.004 0.109 f 0.10 
(2.0) (2.0) 
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Fig. 1. Time-dependent labelling of phosphatidylinositol in different 
proximal tubule cell subcellular fractions. Proximal tubule cell homo- 
genate, 0; brush-border membrane, 0; basolateral membrane, 0; 
microsomes, W; nucleus, A; mitochondria, X. Values represent the 
mean f S.E. of three experiments. 
mitochondrial fractions, consistent with the presence of 
microsomal contamination; however, distinct dif- 
ferences in 32P0, incorporation occurred between mi- 
crosomal and mitochondrial fractions, suggesting that a 
functionally significant separation had been accom- 
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Fig. 1 displays the time-dependent labelling of phos- 
phatidylinositol in the separated subcellular fractions 
expressed as cpm of 32P0, per mg of protein. Whole 
cell homogenates displayed the greatest increase in in- 
corporated counts followed by brush-border, basolateral 
and microsomal membranes, respectively. Subcellular 
labelling was consistently observed to increase to 60 
min and variably plateaued or fell by 90 min. Of note 
was the time-dependent labelling in the nuclear frac- 
tions and the absence of mitochondrial labelling. These 
standard labelling studies were consistent with the pres- 
ence of in situ formation of phosphatidylinositol in 
brush-border and basolateral fractions in addition to 
the microsomal membranes. This possibility was further 
assessed by pulse-chase labelling as shown in Fig. 2. 
Following a 30 min incubation with 32P04, the radio- 
label was removed and cells were further incubated in 
buffer. Microsomal labelling of PI rose to levels higher 
than those observed for either brush-border or baso- 
lateral membranes; 60 min following the removal of 
label microsomal PI continued to rise to comparably 
even greater levels (panel A). In contrast, markedly 
different patterns of labelling were observed for phos- 
phatidylglycerol (panel B), phosphatidylethanolamine 
(panel C) and phosphatidylcholine (panel D). Here, 
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Fig. 2. Pulse-chase labelling of major phospholipids from proximal tubule cell subcellular fractions: (A) phosphatidylinositol; (B) phosphatidyl- 
glycerol; (C) phosphatidylethanolamine; (D) phosphatidylcholine. Brush-border membrane, 0; basolateral membrane, 0; microsomes, n . The data 
are from one of three representative experiments performed in triplicate. 
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TABLE II 
Kinetic measurements of phosphatidylinositol synthase 
Comparisons of the apparent K, values, maximal velocities and microsomal enrichments for microsomes, brushborder and basolateral 
membranes. The ratio of cytochrome-c reductase activity to phosphatidylinositol synthase activity is 3.4times greater than in basolateral 
membranes and 4.0-times greater than that measured in brush-border membranes. Results are the mean * S.E. of five determinations. V,, and K, 
values were not significantly different between membrane fractions by paired t-analysis. 
Sample K, V 











0.315 +0.193 0.118~0.041 0.017 0.144 
0.386 kO.210 0.106 f 0.044 0.012 0.113 
0.231 f 0.046 0.209 f 0.045 0.160 0.766 
corporation of 32P0, in both brush-border and baso- 
lateral membrane phospholipids, consistent with two 
potential interpretations. Either there exists microsomal 
production of these lipids with subsequent shuttling to 
the plasma membrane domains, or in situ formation of 
these products in brush-border and basolateral mem- 
branes occurs at a rate which is significantly less than 
that in the microsomal compartment. Phosphatidyl- 
glycerol synthesis, however, demonstrated the absence 
of non-microsomal labelling immediately following the 
addition of the pulse label, but an increase in plasma 
membrane labelling was observed concomitant with the 
disappearance of microsomal labelling. 
Further assessment of production of PI in the plasma 
membranes and the microsomal fractions of proximal 
tubule cells was carried out by direct measurement of PI 
0 5 10 
Fig. 3. Substrate vs. velocity profiles of microsomal (m), brush-border 
(0) and basolateral membranes (0) as a function of myo-inositol 
concentration. The data are from a representative experiment per- 
formed in triplicate. Correlation coefficients were 0.97, 0.91 and 0.95, 
respectively. 
synthase activity. The apparent K, for myo-inositol of 
the synthase in microsomal, brush-border and baso- 
lateral membranes was measured by varying the con- 
centration of unlabeled myo-inositol from 100 polar to 
10 mmolar. By double-reciprocal plots (Fig. 3), the 
apparent K, values of microsomal, brush-border and 
basolateral membranes were 0.23 * 0.05,0.39 f 0.21 and 
0.31 f 0.19 mM, respectively (N = 6). Similar studies 
were performed to assess the apparent K, values for 
CDP-diacylglycerol in comparable fractions. K, values 
for microsomal, brushborder and basolateral mem- 
branes were 0.12f0.02, 0.14f0.05 and 0.12f0.03 
mM, respectively (N = 4), (Fig. 4). Table II displays the 
V max values and compares them to the marker enzyme, 
cytochrome-c reductase, for the microsomal fractions. 
Although the maximal velocity of the microsomal syn- 
thase activity was slightly greater than that observed for 
-5 0 5 10 15 20 25 
lI[CDP-DIGLYCERIDE] 
Fig. 4. Substrate vs. velocity profiles of microsomal, brush-border and 
basolateral membranes as a function of CDP-diacylglycerol con- 
centration. Symbols are as indicated for Fig. 3. Data are from a 
representative experiment performed in triplicate. Correlation coeffi- 
cients were 0.97,0.97 and 0.98, respectively. 
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TABLE III 
Effects of PI, PIP, PIP, and PC on PI synthase activities associated 
with proximal tubule cells subcellular fractions 
Phospholipids were added to the incubation buffer as sonicated 
dispersions to make a 0.1 mM solution prior to the addition of the 
fractions, PI, phosphatidylinositol; PIP, phosphatidylinositol mono- 
phosphate; PIP,, phosphatidylinositol bisphosphate; PC, phospha- 
tidylcholine. Results are the means of three determinations5 SE. 
* P i 0.05 by paired t-test vs. control. 
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the basolateral and brush-border membranes, this dif- 
ference was not proportionate to the minor degree of 
microsomal contamination. 
The inhibitory effects of phosphatidylinositol on its 
own formation was evaluated by coincubation of indi- 
vidual membrane fractions with increasing concentra- 
tions of phosphatidylinositol and the assay buffer. Ex- 
ogenously added phosphatidylinositol was observed to 
inhibit the incorporation of myo-[2-3H]inositol into 
phosphatidylinositol in a concentration-dependent fash- 
ion with a Ki of approx. 0.05 mM (data not shown). 
The same pattern of inhibition was observable for each 
fraction. Phosphatidylcholine, phosphatidylinositol 
monophosphate and phosphatidylinositol bisphosphate 
did not exert inhibitory effects under identical condi- 
tions (Table III). 
Finally, proximal cellular myo-inositol content was 
measured in proximal tubule cells by gas-liquid chro- 
matography. Cellular content was 53.3 k 4.3 nmol/mg 
protein (n = 4). Based on previous measurements of cell 
water content obtained using identical tubule isolation 
methods [33], estimated cellular myo-inositol concentra- 
tion was 20.5 mM. 
Discussion 
Phosphatidylinositol synthase is a key enzyme in the 
inositol lipid pathway controlling both the substrate 
available for the formation of the phosphatidylinositol 
polyphosphates and serving as the first dedicated step 
in the utilization of cellular inositol. This enzyme was 
originally described in the kidney by Agranoff [21], 
however, the subcellular localization and regulation of 
phosphatidylinositol synthesis in renal epithelia remains 
poorly understood. The current study provides evidence 
that in fact phosphatidylinositol formation occurs at 
multiple subcellular sites and is not restricted to micro- 
somal fractions. Three types of experiment support this 
interpretation. 
Radiolabelling experiments with carrier-free 32P0, 
were conducted and demonstrated time-dependent in- 
corporation of the radiolabel into multiple subcellular 
fractions. This incorporation included not only the mi- 
crosomal fraction but the plasma membrane and nuclear 
fractions as well. Under these conditions, the rate of 
incorporation of radiolabel was greatest in the brush- 
border membrane and did not appear to differ substan- 
tially among the microsomal, nuclear and basolateral 
membranes. These observations are consistent with in 
situ production of PI in non-microsomal membranes. 
Of additional interest was the observation that the rate 
of phosphatidylinositol synthesis appeared to be greater 
in brush-border than in basolateral membranes. This is 
contrary to comparable observations made by Molitoris 
and Simon [22]. Whether this disparity is due to species 
differences (rabbit vs. rat) or to other unappreciated 
factors is not apparent at present. 
Also noteworthy was the apparent formation of 
phosphatidylinositol in the nuclear fractions. Similar 
observations have been recently reported in Friend 
erythroleukemia cells [23]. However, in the present 
study, additional efforts to strip the microsomal-rich 
nuclear envelope from the nuclei were not undertaken, 
rendering these data more difficult to interpret. How- 
ever, the absence of depletion of nuclear isolates for 
cytochrome-c reductase make it likely that this labelling 
was in fact due to microsomal contamination. 
A second line of evidence for non-microsomal phos- 
phatidylinositol synthesis was the pulse-chase labelling 
performed on microsomal, brush-border and basolateral 
membranes. Each phospholipid studied revealed a pat- 
tern of radiolabeling typified by early microsomal incor- 
poration which peaked or plateaued within 30 min of 
the removal of the pulse. This was followed by a rise in 
the incorporation of 32P04 into both the brush-border 
and basolateral fractions. This was most evident for 
phosphatidylglycerol, where no detectable labelling in 
non-microsomal fractions was evident until 30 min fol- 
lowing the removal of the pulse. The exception to these 
observations was phosphatidylinositol; here, labelling of 
each fraction occurred at a constant rate over the full 
course of the experiment with no obvious relationship 
between the changes in microsomal labelling and plasma 
membrane labelling. The radiolabelled substrate for both 
phosphatidylinositol and phosphatidylglycerol forma- 
tion is [ 32P]CDP-diacylglycerol [24]. Therefore, the dis- 
crepant patterns of labelling between phosphatidyl- 
inositol and phosphatidylglycerol provide strong sup- 
port for the probable differences in sites of synthesis. 
To further explore this hypothesis, PI synthase activ- 
ity was examined in these three subcellular fractions. 
Enzyme activity was readily found in association with 
both plasma membrane domains and in the microsomal 
compartment. The enzyme displayed similar kinetics in 
each of these fractions. The apparent K, values were 
comparable and the reaction was linear with respect to 
time and protein content of the sample. The observed 
V max values for myo-inositol and CDP-DG were 
quantitatively, but only slightly lower, in the basolateral 
and brush-border membranes than in the microsomes 
consistent with a lower specific activity for the synthase 
in these fractions. This difference in activity, however, 
was not quantitatively significant to the point where 
plasma membrane activity could be accounted for by 
microsomal cross-contamination alone as indicated by 
the comparative ratios of the maximal velocities to the 
cytochrome-c reductase activity. Finally, each fraction 
displayed comparable kinetics with respect to inhibition 
by PI and for the specificity of this inhibition. 
Evaluated in concert, these data provide potentially 
useful insight into the regulation of phosphatidylinositol 
synthesis. The existence of distinct sites of phosphati- 
dylinositol synthesis lends credence to the concept that 
there exist both hormone-sensitive and -insensitive pools 
of inositol lipids within cells [25,26]. The identification 
of hormone-responsive changes in both brush-border 
[27] and basolateral membranes [28] suggests that com- 
parable distinctions may exist within the proximal tu- 
bule cell as well. 
Of some interest is that the apparent K, for myo-in- 
ositol in the fractions studied, 0.23 to 0.39 mM, is 
significantly below the encountered cellular concentra- 
tion of myo-inositol. The intracellular myo-inositol con- 
centration observed in the present study is in agreement 
with other reports of myo-inositol levels within the 
kidney [29] and other tissues [30]. Thus, under condi- 
tions in which cellular inositol levels fall (e.g., diabetes 
mellitus) [31-331, or in which inositol content may 
compensatorily rise (e.g., antidiuresis) [34], phosphati- 
dylinositol synthesis may be unaffected, since myo- 
inositol would be present at levels significantly greater 
than those required to saturate the enzyme. 
Few studies have been conducted to assess in detail 
the kinetics of phosphatidylinositol synthesis and de- 
gradation in renal epithelia under abnormal metabolic 
conditions such as the diabetic environment. Cohen [30] 
has shown that rat glomerular phosphatidylinositol con- 
tent did not fall when rats were rendered diabetic with 
streptozotocin, despite a significant drop in the glomer- 
ular myo-inositol content in these animals. Also suppor- 
tive of the ‘non-regulation’ of phosphatidylinositol by 
cellular inositol levels is the observation that phosphati- 
dylinositol synthase activity is inhibited by its forma- 
tion product. This observation confirms that of Imai 
and Gershengorn in GH3 cells [35]. 
The present study supports the concept that in prox- 
imal tubule cells the regulation of phosphatidylinositol 
synthesis is tightly regulated and is unlikely to be af- 
fected by even considerable changes in cellular inositol 
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content. The question as to whether or not a fall in 
intracellular myo-inositol concentration analogous to 
that observed in the glomeruli and nerves of diabetic 
animals or a rise in cellular inositol such as that ob- 
served under hyperosmolar conditions would affect 
phosphatidylinositol content in other renal tissues is an 
important issue requiring further investigation. Such 
studies, however, should be substantiated not only by 
direct chemical measurement of inositol lipid levels, as 
others have done, but by characterization of the phos- 
phatidylinositol synthase under these conditions as well. 
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